NeoGenomics Inc (NEO) stock
NEONasdaqServices-Testing LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 11/3023% below fair value
$15.25−0.16 (-1.04%)
Close on Nov 17, 2026Market cap $1.97BP/E –Yield –
NeoGenomics profit margin
Profit margin (net margin) is net income as a percentage of revenue.
NeoGenomics's profit margin for the twelve months ending Sep 30, 2026 was -4.1%. For fiscal 2025 it was -14.9%, against -11.9% the year before. The highest annual figure on record is 3.1% in fiscal 2013.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -14.9% | −2.9 |
| FY2024 | Dec 31, 2024 | -11.9% | +3.0 |
| FY2023 | Dec 31, 2023 | -14.9% | +13.4 |
| FY2022 | Dec 31, 2022 | -28.3% | −26.6 |
| FY2021 | Dec 31, 2021 | -1.7% | −2.7 |
| FY2020 | Dec 31, 2020 | 0.9% | −1.0 |
| FY2019 | Dec 31, 2019 | 2.0% | +1.0 |
| FY2018 | Dec 31, 2018 | 1.0% | +1.1 |
| FY2017 | Dec 31, 2017 | -0.2% | +2.5 |
| FY2016 | Dec 31, 2016 | -2.6% | −0.1 |
| FY2015 | Dec 31, 2015 | -2.5% | −3.8 |
| FY2014 | Dec 31, 2014 | 1.3% | −1.8 |
| FY2013 | Dec 31, 2013 | 3.1% | +3.0 |
| FY2012 | Dec 31, 2012 | 0.1% | +2.8 |
| FY2011 | Dec 31, 2011 | -2.7% | +6.9 |
| FY2010 | Dec 31, 2010 | -9.6% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -3.6% | +10.8 |
| Q2 FY2026 | Jun 30, 2026 | 1.1% | +26.0 |
| Q1 FY2026 | Mar 31, 2026 | -9.2% | +6.3 |
| Q4 FY2025 | Dec 31, 2025 | -5.2% | +3.7 |
| Q3 FY2025 | Sep 30, 2025 | -14.4% | −3.9 |
| Q2 FY2025 | Jun 30, 2025 | -24.9% | −13.5 |
| Q1 FY2025 | Mar 31, 2025 | -15.4% | +1.9 |
| Q4 FY2024 | Dec 31, 2024 | -8.9% | +0.3 |
| Q3 FY2024 | Sep 30, 2024 | -10.5% | +1.6 |
| Q2 FY2024 | Jun 30, 2024 | -11.3% | +5.2 |
| Q1 FY2024 | Mar 31, 2024 | -17.3% | +5.1 |
| Q4 FY2023 | Dec 31, 2023 | -9.2% | +7.1 |
| Q3 FY2023 | Sep 30, 2023 | -12.2% | +16.4 |
| Q2 FY2023 | Jun 30, 2023 | -16.6% | +11.7 |
| Q1 FY2023 | Mar 31, 2023 | -22.4% | +19.7 |
| Q4 FY2022 | Dec 31, 2022 | -16.4% | +16.9 |
| Q3 FY2022 | Sep 30, 2022 | -28.6% | −11.8 |
| Q2 FY2022 | Jun 30, 2022 | -28.2% | −90.6 |
| Q1 FY2022 | Mar 31, 2022 | -42.2% | −23.0 |
| Q4 FY2021 | Dec 31, 2021 | -33.2% | −45.4 |
| Q3 FY2021 | Sep 30, 2021 | -16.8% | −18.8 |
| Q2 FY2021 | Jun 30, 2021 | 62.3% | +70.2 |
| Q1 FY2021 | Mar 31, 2021 | -19.1% | −12.6 |
| Q4 FY2020 | Dec 31, 2020 | 12.2% | +6.3 |
| Q3 FY2020 | Sep 30, 2020 | 2.0% | −0.0 |
| Q2 FY2020 | Jun 30, 2020 | -7.8% | −9.8 |
| Q1 FY2020 | Mar 31, 2020 | -6.6% | −4.0 |
| Q4 FY2019 | Dec 31, 2019 | 5.9% | +5.4 |
| Q3 FY2019 | Sep 30, 2019 | 2.0% | −0.9 |
| Q2 FY2019 | Jun 30, 2019 | 2.0% | +2.5 |
| Q1 FY2019 | Mar 31, 2019 | -2.5% | −3.6 |
| Q4 FY2018 | Dec 31, 2018 | 0.5% | −6.9 |
| Q3 FY2018 | Sep 30, 2018 | 2.9% | +10.1 |
| Q2 FY2018 | Jun 30, 2018 | -0.6% | −1.3 |
| Q1 FY2018 | Mar 31, 2018 | 1.0% | +3.0 |
| Q4 FY2017 | Dec 31, 2017 | 7.4% | +17.7 |
| Q3 FY2017 | Sep 30, 2017 | -7.2% | – |
| Q2 FY2017 | Jun 30, 2017 | 0.8% | – |
| Q1 FY2017 | Mar 31, 2017 | -2.0% | – |
| Q4 FY2016 | Dec 31, 2016 | -10.3% | – |
See a number that looks wrong?